Preview Mode Links will not work in preview mode

Oncology Overdrive


Jun 8, 2020

Vinay Prasad, MD, MPH, an academic oncologist and host of the podcast Plenary Session, shares insight on his recently published book Malignant, his thoughts on the unsustainability of the current state of oncology, and provides guidance on how to navigate modern day oncology and the complexities of constantly evolving cancer care.

Intro :13

About Dr. Prasad :17

The interview 1:20

How did you get here? 2:05

How to stay out of hot water 5:28

How do you navigate everything? 8:38

How can others navigate through all of the information? 13:32

What is important from the first section of your book? 16:42

Dealing with cost questions 21:22

The impact of social media on health care and cancer care 23:51

The distinction between precision oncology and personalized care 30:16

What are your biggest takeaways from the last section of your book? 34:21

What are your hopes for cancer care? 37:59

What’s next for you? 43:20

Final thoughts from Dr. Prasad 46:02

How to find Dr. Prasad on social media and buy his book 48:05

We’d love to hear from you! Send your comments/questions to oncologyoverdrive@healio.com. Follow us on Twitter @HemOncToday @ShikhaJainMD @VPrasadMDMPH

Vinay Prasad, MD, MPH, is a practicing hematologist-oncologist and associate professor of medicine at the University of California San Francisco. He studies cancer drugs, health policy and evidence-based medicine. He is author of over 200 academic articles, and the books Ending Medical Reversal (2015), and Malignant (2020). He hosts the oncology podcast Plenary Session.

Disclosures: Jain reports she is a paid freelance writer for Lippincott. Prasad reports receiving research funding from Arnold Ventures; royalties from Johns Hopkins Press and Medscape; honoraria for grand rounds/lectures from universities, medical centers, nonprofits and professional societies; consulting from UnitedHealtcare; and speaking fees from Evicore. He reports his podcast Plenary Session has Patreon backers.